---
title: "301371.SZ (301371.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/301371.SZ/news.md"
symbol: "301371.SZ"
name: "301371.SZ"
parent: "https://longbridge.com/zh-HK/quote/301371.SZ.md"
datetime: "2026-03-17T07:32:23.912Z"
locales:
  - [en](https://longbridge.com/en/quote/301371.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301371.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301371.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/301371.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/301371.SZ/news.md)


# 301371.SZ (301371.SZ) — 相關新聞

### [](https://longbridge.com/zh-HK/news/278702176.md)
*2026-03-11T10:19:12.000Z*
> Fuerjia stated during a specific audience survey that the restructured type III humanized collagen freeze-dried fibers h

### [Fuerjia: This year will further expand OTC channels to increase pharmacy coverage](https://longbridge.com/zh-HK/news/278662536.md)
*2026-03-11T05:25:28.000Z*
> Fuerjia (301371) stated in an investor relations activity that it will further expand its OTC channels this year to incr

### [Fuerjia: Continuously focusing on external mergers and acquisitions, currently no suitable targets](https://longbridge.com/zh-HK/news/277708097.md)
*2026-03-04T01:55:07.000Z*
> Fuerjia (301371) disclosed the investor relations activity record showing that the company received research visits from

### [Fuerjia: The clinical trial for the research product Reorganized Type III Humanized Collagen Freeze-Dried Fiber has been completed](https://longbridge.com/zh-HK/news/276707849.md)
*2026-02-24T09:03:02.000Z*
> Fuerjia announced that its research product "Recombinant Type III Humanized Collagen Lyophilized Fiber" has completed cl